Literature DB >> 85210

Instability of pancreatic endocrine cell populations throughout life.

L Orci, Y Stefan, F Malaisse-Lagae, A Perrelet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 85210     DOI： 10.1016/s0140-6736(79)91050-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide.

Authors:  F Malaisse-Lagae; Y Stefan; J Cox; A Perrelet; L Orci
Journal:  Diabetologia       Date:  1979-12       Impact factor: 10.122

2.  Multiple hormone storage by 'polycrine' cells in the pancreas (from a case of nesidioblastosis).

Authors:  G R Newman; B Jasani; E D Williams
Journal:  Histochem J       Date:  1986 Feb-Mar

3.  Abundance of somatostatin cells in the human neonatal pancreas.

Authors:  J Rahier; J Wallon; J C Henquin
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

4.  Plasma somatostatin concentration in the preterm neonate.

Authors:  L Sann; J A Chayvialle; F Descos
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

5.  Neonatal pig pancreatic islets for transplantation.

Authors:  C Y Kuo; A Myracle; G A Burghen; H G Herrod
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-09       Impact factor: 2.416

6.  Cell populations in the endocrine pancreas of human neonates and infants.

Authors:  J Rahier; J Wallon; J C Henquin
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

7.  Quantitative morphology of endocrine cells in human fetal pancreas.

Authors:  A Clark; A M Grant
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

8.  Oreocnide integrifolia Flavonoids Augment Reprogramming for Islet Neogenesis and β-Cell Regeneration in Pancreatectomized BALB/c Mice.

Authors:  Bhavna Bharucha; Malati Umarani; Mitesh Dwivedi; Naresh C Laddha; Rasheedunnisa Begum; Anandwardhan A Hardikar; A V Ramachandran
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-27       Impact factor: 2.629
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.